Company Monitoring Page for Astellas

latest headlines for company on cafepharma

FDA panel backs Astellas drug for invasive fungal infections
Yahoo/Reuters
Thu, 01/22/15 - 02:34 pm
Tags:
FDA, Astellas, advisory panels, Isavuconazonium, fungal infections
Astellas' Isavuconazonium Should Pass Ad Comm Meeting For 2 Indications
Seeking Alpha
Wed, 01/21/15 - 12:00 pm
Tags:
Astellas, Isavuconazonium, FDA, advisory panels, aspergillosis, mucormycosis
Astellas adds to deal spree with expanded $675M-plus Cytokinetics pact
Fierce Biotech
Tue, 12/23/14 - 10:01 am
Tags:
Astellas, Cytokinetics, CK-2127107, spinal muscular atrophy
Data Presented From Phase 2 Study of Enzalutamide in Advanced Androgen-Receptor Positive, Triple-Negative Breast Cancer
Yahoo/MarketWired
Sat, 12/13/14 - 11:26 am
Tags:
Enzalutamide, Medivation, Astellas, breast cancer
J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III
Fierce Biotech
Tue, 12/2/14 - 09:25 am
Tags:
JNJ, Astellas, rheumatoid arthritis, ASP015K, JAK inhibitors
3 Biotech Stocks Growing Faster Than Gilead Sciences Inc.
Motley Fool
Mon, 10/27/14 - 08:10 am
Tags:
biotech, Gilead Sciences, Medivation, Astellas, Celgene, Biogen Idec
Astellas dives into gene therapy with a Harvard expert in tow
Fierce Biotech
Tue, 10/14/14 - 09:23 pm
Tags:
Astellas, gene therapy, Retinitis pigmentosa
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Tags:
Zytiga, Xtandi, JNJ, prostate cancer, Medivation, Astellas
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Mon, 09/15/14 - 07:30 pm
Tags:
Xtandi, Medivation, Astellas, hirings, JNJ, Zytiga
Astellas files new drug for life-threatening infections
Pharmaphorum
Mon, 09/8/14 - 08:19 am
Tags:
Astellas, isavuconazole, antifungals
Astellas Seeks FDA Nod for Fungal Infection Treatment
Yahoo/Zacks.com
Thu, 07/10/14 - 05:50 pm
Tags:
Astellas, FDA, fungal infections, isavuconazole
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Sun, 06/1/14 - 11:40 am
Tags:
Enzalutamide, prostate cancer, metastatic prostate cancer, Xtandi, Astellas
Cytokinetics initiates multiple dose Phase I clinical trial of CK-2127107
The Fly on the Wall
Thu, 03/27/14 - 08:18 am
Tags:
Cytokinetics, CK-2127107, Astellas
Aveo, Astellas end pact to develop cancer drug Tivozanib
Yahoo/Reuters
Fri, 02/14/14 - 11:57 am
Tags:
Aveo, Astellas, tivozanib, colon cancer
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
Tags:
AbbVie, Enanta Pharmaceuticals, ABT-450, hepatitis C, Medivation, Xtandi, prostate cancer, Astellas, Geron, imetelstat, PSMA-ADC, Progenics Pharmaceuticals, Idenix
Aveo Oncology to end breast cancer study due to low enrollment
Yahoo/Reuters
Thu, 01/30/14 - 10:07 am
Tags:
Aveo Oncology, Astellas, tivozanib, breast cancer, clinical trials
Medivation Inc. and Astellas Up the Ante against Johnson & Johnson
Motley Fool
Wed, 01/29/14 - 05:46 pm
Tags:
Medivation, Astellas, JNJ, Zytiga, Xtandi, prostate cancer
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
Tags:
JNJ, Medivation, prostatce cancer, Astellas, Dendreon, Sanofi, Zytiga, Xtandi, Provenge
FDA warns of heart risks with Astellas' Lexiscan and Adenoscan
Reuters
Wed, 11/20/13 - 11:14 am
Tags:
FDA, Astellas, Lexiscan, Adenoscan
Johnson & Johnson Vs. Medivation In Prostate Cancer Race
Seeking Alpha
Mon, 11/18/13 - 08:19 am
Tags:
JNJ, Medivation, prostate cancer, Xtandi, Astellas, Zytiga

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.